Thompson John Craig
Esperion Therapeutics, Inc. · Director
Thompson John Craig is listed in filings as Director at Esperion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including 2 public disclosures. Recent filings connect the profile to Esperion Therapeutics, Inc. (ESPR). The current snapshot covers public activity from Jul 2, 2025 to Jun 1, 2026. Reported amounts are shown as $40.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||